BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26806565)

  • 1. The Safety of Drug Therapy in Children.
    Wimmer S; Neubert A; Rascher W
    Dtsch Arztebl Int; 2015 Nov; 112(46):781-7. PubMed ID: 26806565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs.
    Dubrall D; Leitzen S; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):56. PubMed ID: 34620231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
    Aagaard L; Hansen EH
    Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated identification of antibiotic overdoses and adverse drug events via analysis of prescribing alerts and medication administration records.
    Kirkendall ES; Kouril M; Dexheimer JW; Courter JD; Hagedorn P; Szczesniak R; Li D; Damania R; Minich T; Spooner SA
    J Am Med Inform Assoc; 2017 Mar; 24(2):295-302. PubMed ID: 27507653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
    Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
    Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
    Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions.
    Thiesen S; Conroy EJ; Bellis JR; Bracken LE; Mannix HL; Bird KA; Duncan JC; Cresswell L; Kirkham JJ; Peak M; Williamson PR; Nunn AJ; Turner MA; Pirmohamed M; Smyth RL
    BMC Med; 2013 Nov; 11():237. PubMed ID: 24228998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of computer order entry on prevention of serious medication errors in hospitalized children.
    Walsh KE; Landrigan CP; Adams WG; Vinci RJ; Chessare JB; Cooper MR; Hebert PM; Schainker EG; McLaughlin TJ; Bauchner H
    Pediatrics; 2008 Mar; 121(3):e421-7. PubMed ID: 18310162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Professional, structural and organisational interventions in primary care for reducing medication errors.
    Khalil H; Bell B; Chambers H; Sheikh A; Avery AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003942. PubMed ID: 28977687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
    Gotta V; van den Anker J; Pfister M
    Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
    Dequito AB; Mol PG; van Doormaal JE; Zaal RJ; van den Bemt PM; Haaijer-Ruskamp FM; Kosterink JG
    Drug Saf; 2011 Nov; 34(11):1089-100. PubMed ID: 21981436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia.
    Dedefo MG; Mitike AH; Angamo MT
    BMC Pediatr; 2016 Jul; 16():81. PubMed ID: 27387547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
    Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
    Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the reporting of adverse drug reactions in children and adolescents in Germany in the time period from 2000 to 2019.
    Leitzen S; Dubrall D; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B
    PLoS One; 2021; 16(3):e0247446. PubMed ID: 33657139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.